| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
New Brunswick, N.J.--
As part of recent definitive agreements, Cilag GmbHInternational, a wholly-owned subsidiary of Johnson & Johnson, will acquirethe over-the-counter brands of J.B. Chemicals & Pharmaceutical Limited(JBCPL) for the equivalent of approximately $260 million in cash. Among thebrands Cilag will be acquiring are RINZA, Russia's leading multi-symptom coughand cold brand, DOKTOR MOM, the number two selling cough brand in Russia andFitovit, as well as other brands. Johnson & Johnson LLC, another subsidiaryof J&J, will market the products in Russia, as well as in the Commonwealthof Independent States and other countries.
 
"Emerging markets continue to be an important growthopportunity for Johnson & Johnson," says Jesse Wu, Worldwide Chairman,Johnson & Johnson Group of Consumer Companies. "This acquisition of strongbrands in Russia will allow us to expand our OTC offerings in these growthmarkets and support our emerging markets strategy."
 
J.B. Mody, chairman of JBCPL,calls the transaction "a testimony to the quality & competitiveness ofJBCPL's branded product portfolio and its world class manufacturingcapabilities."
 
"The divestment will provide JBCPL with the financialflexibility to pursue new growth opportunities in India and other focusmarkets," says Mody. "We are confident that Johnson & Johnson will take ourbusiness in Russia/CIS to even greater heights."
 
Johnson & Johnson expects the acquisition to close bymid-2011, subject to customary closing conditions.
 
 
JBCPL brought Bank of AmericaMerrill Lynch on as exclusive financial advisor for the transaction.
 
 

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

GreenCooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue